DavidPBenderMD
Obstetrics & Gynecology • Iowa City, IAGynecologic Oncology
Clinical Professor of Obstetrics & Gynecology, University Iowa College of Medicine
Dr. Bender is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Hawkins Drive
Ste 100
Iowa City, IA 52242Phone+1 319-356-1616Fax+1 319-353-8363- Is this information wrong?
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Gynecologic Oncology, 2001 - 2004
UPMC Medical EducationResidency, Obstetrics and Gynecology, 1995 - 1999
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1995
Certifications & Licensure
IA State Medical License 2000 - 2025
KY State Medical License 1999 - 2001
PA State Medical License 1996 - 2000- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2009 Oct 28
- Join now to see all
Publications & Presentations
PubMed
- Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/EN...Pothuri, B., Han, S., Chase, D., Heitz, F., Burger, R., Gaba, L., Van Le, L., Guerra, E., Bender, D., Korach, J., Cloven, N., Churruca, C., Follana, P., DiSilvestro, P...> ;Gynecologic Oncology. 2024 Feb 6
- Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation.Jesus Gonzalez-Bosquet, Megan E McDonald, David P Bender, Brian J Smith, Kimberly K Leslie, Michael J Goodheart, Eric J Devor> ;Cancers. 2023 Jun 23
- The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5)...Tiffany Y Sia, William P Tew, Christopher Purdy, Dennis S Chi, Andrew W Menzin, John L Lovecchio, Michael A Bookman, David E Cohn, Deanna G Teoh, Michael Friedlander, ...> ;Gynecologic Oncology. 2023 Jun 1
- Join now to see all
Press Mentions
University of Iowa Hospitals and Clinics' Pioneering Vision of Hospital Art Impacts HealingSeptember 26th, 2019
Hospital Affiliations
University of Iowa Hospitals and ClinicsIowa City, Iowa
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
